Making Medicines affordable.
News Room
Latest NewsPress Releases
Releases 2007 Releases 2006 Releases 2005 Releases 2004 Releases 2003Media Kit
Handy InfoPress Releases
2006
PRESS RELEASE: 5 December 2006
IAPO PAPER IGNORES THE SCIENCE OF BIOSIMILARSEuropean producers of biosimilar medicines have raised doubts over the reliability of a paper launched today by the International Alliance of Patients’ Organisations (IAPO).
PRESS RELEASE: 29 September 2006
EGA SUPPORTS SUSTAINABILITY AND INNOVATION AT EU PHARMACEUTICAL FORUMEGA President Emile Loof underscored the critical role of generic medicines in sustaining healthcare provision and in stimulating innovation.
EGA NEWS: 29 September 2006
EGA PRIORITIES 2007Greg Perry, Director General of the European Generic medicines Association, Outlines the Association's Top 10 Priority Areas by way of summarising the 12th EGA Annual Meeting in Budapest.
PRESS RELEASE: 28 September 2006
EGA WELCOMES PATENT DECISIONThe EGA welcomes the decision by the European Patent Office to revoke "Citalopram crystalline base" patent for lack of inventive step.
PRESS RELEASE: 22 September 2006
COUNTERFEIT MEDICINES:“Business with Certified Partners Only”
EGA President Emile Loof calls upon the entire pharmaceutical industry to join forces against the problem of counterfeit medicines.
PRESS RELEASE: 19 September 2006
EGA AWARD 2006 IS GRANTED TO BHFThe Executive Committee of the European Generic medicines Association (EGA) has voted unanimously to grant the 2006 edition of the EGA Award to the Business Humanitarian Forum (BHF).
PRESS RELEASE: 18 May 2006
BIOSIMILAR PRODUCTS: A REALITY IN EUROPEAt the opening of the 4th Annual EGA Symposium on Biosimilar Medicines in London, the EGA welcomed the European Commission’s recent approval of two biosimilar products as vindication of their belief in the ability of science to demonstrate comparability.
PRESS RELEASE: 3 May 2006
2nd EGA South East Europe Pharmaceutical SymposiumMAINTAINING PATIENT ACCESS TO AFFORDABLE MEDICINES IN THE REGION
EU Accession Countries must to be wary of creating obstacles to the production of generic medicines when adapting their legislation to the acquis communautaire.
PRESS RELEASE: 6 April 2006
STUDY URGES COHERENT PROMOTION OF GENERIC MEDICINES TO SUSTAIN HEALTHCARE PROVISIONA new study by the Katholieke Universiteit Leuven shows that added savings of 27%-48% could be attained if the appropriate measures were taken by EU Member States.
PRESS RELEASE: 2 February 2006
NEW STRATEGY ON PATENT LINKAGE IS CONTRARY TO EU LAW AND THREATENS ACCESS TO COMPETITIVE GENERIC MEDICINESGreg Perry, Director General of European Generic medicines Association, announced today in London that growing pressure on European medicines authorities to apply patent linkage constitutes one of the biggest threats currently facing the generic medicines industry.
The EGA
“In an era when increasing demands are being made on Europe’s healthcare services, generic medicines provide a major benefit to society as they ensure patient access to quality, safe and effective medicines while reducing the cost of medicinal care.”
The EGA is the official representative body of the European generic pharmaceuticals industry, which is at the forefront of providing high-quality affordable medicines to millions of Europeans while stimulating competitiveness and innovation in the pharmaceutical sector.
The EGA represents over 500 companies and their subsidiaries from greater Europe, and over 100,000 jobs. Generic medicines save €18 billion each year for health care systems and patients.
For further information:
About the EGA About Generics